本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Rhythm Pharmaceuticals Inc.

57.38
-3.3400-5.50%
盘后57.380.00000.00%18:47 EDT
成交量:89.55万
成交额:5,259.00万
市值:36.49亿
市盈率:-20.32
高:62.28
开:60.73
低:57.28
收:60.72
数据加载中...
2023/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/03

重要事件披露

Form 8-K - Current report
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

重要事件披露

8-K - Current report
2023/03/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/10

重要事件披露

8-K - Current report
2023/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/01

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/01

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals